[Prognostic value of gliofibrillary protein assay in malignant gliomas treated with chemo- and radiotherapy].
The value of GFA determination for predicting the survival of patients after surgical treatment of a malignant brain tumor was studied. GFA was measured on a histologically controlled fragment of the tumor. No significant correlation was found between the level of GFA and the survival time of patients treated by chemotherapy and radiotherapy.
D000293:Adolescent; D000328:Adult; D001932:Brain Neoplasms / Q000032:analysis* / Q000188:drug therapy / Q000532:radiotherapy; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D005904:Glial Fibrillary Acidic Protein; D005910:Glioma / Q000032:analysis* / Q000188:drug therapy / Q000532:radiotherapy; D006801:Humans; D007381:Intermediate Filament Proteins / Q000032:analysis*; D008130:Lomustine / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D013713:Teniposide / Q000008:administration & dosage
D005904:Glial Fibrillary Acidic Protein; D007381:Intermediate Filament Proteins; D008130:Lomustine; D013713:Teniposide
Valeur pronostique du dosage de la protéine glio-fibrillaire dans les gliomes malins traités par chimio- et radiothérapie.